Stock Charts
HOME
WATCHLIST
PORTFOLIO
114
SUMMARY
INDICES
SECTORS
MOVERS
RATES
FUTURES
JOBS
Symbol Lookup
WallStreetSelect 114
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
Amgen, Inc.
(NQ:
AMGN
)
104.53
USD
+0.29 (+0.28%)
Official Closing Price
/ Updated:
8:10 PM EDT, May 22, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Amgen, Inc.
< Previous
1
2
3
4
5
6
7
8
9
...
35
36
Next >
Amgen Announces Voting Results of Annual Meeting of Stockholders
May 22, 2013
from
PR Newswire
RBCC Opens Talks to Acquire Tech Innovators in $142 Billion Drug Delivery Market
May 21, 2013
from
Business Wire News Releases
Amgen To Present At The UBS Global Life Sciences Conference
May 16, 2013
from
PR Newswire
Transgenomic Announces Global Availability of CRC RAScan™ Mutation Detection Test for Use in Patients with Metastatic Colorectal Cancer to Help Identify Appropriate Treatment
May 16, 2013
from
Business Wire News Releases
New Analyses Identify Predictive Biomarkers For Vectibix® (Panitumumab) In Patients With Metastatic Colorectal Cancer
May 15, 2013
Biomarker Analysis From Phase 3 PRIME ('203) Study and Phase 2 PEAK ('509) Study Link Additional RAS Gene Mutations to Vectibix Clinical Response
Read More
from
PR Newswire
Amgen Highlights Data To Be Presented At American Society of Clinical Oncology Annual Meeting
May 15, 2013
from
PR Newswire
RBCC Partner n3D Signs U.S. Distribution Agreement
May 13, 2013
from
Business Wire News Releases
Strategy Behind Our Success, We Get in Early: PSX, AMGN, MPC and BAX
May 11, 2013
from
Marketwired News Releases
Amgen And Zhejiang Beta Pharma Announce Planned Joint Venture In China
May 09, 2013
Goal Is to Bring Amgen's Vectibix® (Panitumumab) to Chinese Patients
Read More
from
PR Newswire
Amgen Announces Top-Line Results of Vectibix® (panitumumab) Phase 3 Head-to-Head Study Against Erbitux® (cetuximab) in Metastatic Colorectal Cancer
May 07, 2013
Study Meets Primary Endpoint of Non-Inferiority in Monotherapy Setting
Read More
from
PR Newswire
Transgenomic Signs Collaboration Agreement with Amgen for Development of CE-IVD CRC RAScan™ Mutation Detection Tests for Patients with Metastatic Colorectal Cancer
May 06, 2013
from
Business Wire News Releases
World’s Premiere Science Journal Touts Revolutionary Innovations by RBCC Partner Nano3D
May 06, 2013
from
Business Wire News Releases
The Reason It Trades, What's Moving AMGN, VLO and OIS
May 02, 2013
from
Marketwired News Releases
Four Californians Selected as Breakaway from Cancer® Champions to be Honored During Amgen Tour of California
May 01, 2013
Amgen's Breakaway from Cancer to Celebrate Cancer Survivors at Every Stage of the Eighth Annual Professional Cycling Race
Read More
from
PR Newswire
Key to Success, How to Profit: CAT, EMC, AMGN and KO
May 01, 2013
from
Marketwired News Releases
The Real Story Behind BIIB, AMGN, EMC and DIS
April 30, 2013
from
Marketwired News Releases
RBCC: Personalized Medicine Poised to Revolutionize Insurance & Pharmaceuticals
April 30, 2013
from
Business Wire News Releases
Free Research Reports on AMGN, OPK, SLAB and VOCS Issued by the Bedford Report
April 26, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit
Read More
from
Marketwired News Releases
The Reason It Trades, What's Moving PLD, AKAM, GE and AMGN
April 26, 2013
from
Marketwired News Releases
RBCC Looks Overseas for Potentially Lucrative Licensing Opportunities
April 24, 2013
from
Business Wire News Releases
Amgen's First Quarter 2013 Revenues Increased 5 Percent To $4.2 Billion And Adjusted Earnings Per Share (EPS) Increased 22 Percent To $1.96
April 23, 2013
First Quarter 2013 GAAP EPS Were $1.88
Read More
from
PR Newswire
Critical Alerts For Amgen, Peabody Energy, CME, MDC Holdings, and Hanesbrands Released By InvestorsObserver
April 23, 2013
from
PR Newswire
Amgen Announces Webcast of 2013 First Quarter Financial Results
April 18, 2013
from
PR Newswire
Perfect Trade Setups, How to Play AMGN, GILD, JCP and PCLN
April 15, 2013
from
Marketwired News Releases
RBCC Nears Deal With Leading Genetic Testing Lab
April 15, 2013
from
Business Wire News Releases
The Real Story Behind AMGN, NWSA, VLO and AXP
April 12, 2013
from
Marketwired News Releases
In the Know, Smart Investing in AA, MET and AMGN
April 10, 2013
from
Marketwired News Releases
The Straight Truth, Investing in UNH, JCP and AMGN
April 09, 2013
from
Marketwired News Releases
Don't Miss Gains in AMGN, LVS, PG and CELG
April 08, 2013
from
Marketwired News Releases
RBCC Targets Companion Diagnostics Opportunities in Booming $232 Billion Personalized Medicine Market
April 08, 2013
from
Business Wire News Releases
< Previous
1
2
3
4
5
6
7
8
9
...
35
36
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
